propranolol has been researched along with Weight Gain in 15 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| "3837 Men and women randomised 5-21 days after an acute myocardial infarction to treatment with placebo or propranolol for up to 40 months." | 9.06 | Long term propranolol treatment and changes in body weight after myocardial infarction. ( Byington, RP; Furberg, CD; Rössner, S; Taylor, CL, 1990) |
| "To present the outcomes of fixed doses of propranolol tablets for the treatment of hemangiomas." | 7.91 | EFFECTIVENESS OF FIXED DOSES OF PROPRANOLOL IN THE TREATMENT OF HEMANGIOMAS REGARDLESS OF CHILD'S WEIGHT GAIN: A CASE REPORT. ( Anger, J; Gabel, J; Oliveira, EM, 2019) |
| " Chronic administration of propranolol (5 or 50 mg." | 5.29 | Effects of propranolol and atenolol on immobilization stress-induced hypertension and down-regulation of central beta-adrenoceptors in rats. ( Kigoshi, S; Muramatsu, I; Oda, Y; Takita, M, 1995) |
| " Fifty subjects met the DSM-III-R criteria for schizophrenia or schizoaffective disorder, participated in a 10-week, double-blind comparison of haloperidol and clozapine and a 1-year, open-label clozapine trial, and had available serum glucose and lipid levels." | 5.10 | Serum glucose and lipid changes during the course of clozapine treatment: the effect of concurrent beta-adrenergic antagonist treatment. ( Ball, P; Baymiller, SP; Buchanan, RW; McMahon, RP, 2003) |
| "3837 Men and women randomised 5-21 days after an acute myocardial infarction to treatment with placebo or propranolol for up to 40 months." | 5.06 | Long term propranolol treatment and changes in body weight after myocardial infarction. ( Byington, RP; Furberg, CD; Rössner, S; Taylor, CL, 1990) |
| "To present the outcomes of fixed doses of propranolol tablets for the treatment of hemangiomas." | 3.91 | EFFECTIVENESS OF FIXED DOSES OF PROPRANOLOL IN THE TREATMENT OF HEMANGIOMAS REGARDLESS OF CHILD'S WEIGHT GAIN: A CASE REPORT. ( Anger, J; Gabel, J; Oliveira, EM, 2019) |
| " Addition of eugenosedin-A to the high-fat diet resulted in less weight gain and reduced hyperglycaemia, hyperinsulinaemia and hyperlipidaemia." | 3.75 | Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet. ( Chen, IJ; Hsieh, SL; Kwan, AL; Lin, HL; Shen, KP; Wu, BN, 2009) |
| "Propranolol was somewhat better than flunarizine in reducing the severity of migraine attacks, although this may have been due to a selection bias." | 2.68 | Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine. ( Amery, WK; De Locht, P; Verspeelt, J, 1996) |
| " Chronic administration of propranolol (5 or 50 mg." | 1.29 | Effects of propranolol and atenolol on immobilization stress-induced hypertension and down-regulation of central beta-adrenoceptors in rats. ( Kigoshi, S; Muramatsu, I; Oda, Y; Takita, M, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (46.67) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Boyraz, RK | 1 |
| Şahan, E | 1 |
| Kırpınar, İ | 1 |
| Matsumura, S | 1 |
| Ishikawa, F | 1 |
| Sasaki, T | 1 |
| Odanaka, M | 1 |
| Manio, MCC | 1 |
| Fushiki, T | 1 |
| Inoue, K | 1 |
| Anger, J | 1 |
| Oliveira, EM | 1 |
| Gabel, J | 1 |
| Shen, KP | 1 |
| Lin, HL | 1 |
| Hsieh, SL | 1 |
| Kwan, AL | 1 |
| Chen, IJ | 1 |
| Wu, BN | 1 |
| An, S | 1 |
| Han, JI | 1 |
| Kim, MJ | 1 |
| Park, JS | 1 |
| Han, JM | 1 |
| Baek, NI | 1 |
| Chung, HG | 1 |
| Choi, MS | 1 |
| Lee, KT | 1 |
| Jeong, TS | 1 |
| Baymiller, SP | 1 |
| Ball, P | 1 |
| McMahon, RP | 1 |
| Buchanan, RW | 1 |
| Shikara, MM | 1 |
| Polena, S | 1 |
| Solinas, A | 1 |
| Sanghvi, K | 1 |
| Gintautas, J | 1 |
| Maggioni, F | 1 |
| Ruffatti, S | 1 |
| Dainese, F | 1 |
| Mainardi, F | 1 |
| Zanchin, G | 1 |
| Takita, M | 1 |
| Oda, Y | 1 |
| Kigoshi, S | 1 |
| Muramatsu, I | 1 |
| Martínez-Mir, I | 1 |
| Navarro-Badenes, J | 1 |
| Palop, V | 1 |
| Morales-Olivas, FJ | 1 |
| Rubio, E | 1 |
| Verspeelt, J | 1 |
| De Locht, P | 1 |
| Amery, WK | 1 |
| Cusin, I | 1 |
| Terrettaz, J | 1 |
| Rohner-Jeanrenaud, F | 1 |
| Jeanrenaud, B | 1 |
| Rössner, S | 1 |
| Taylor, CL | 1 |
| Byington, RP | 1 |
| Furberg, CD | 1 |
| Kudlacz, EM | 1 |
| Navarro, HA | 1 |
| Eylers, JP | 1 |
| Slotkin, TA | 1 |
| Berenson, GS | 1 |
| Shear, CL | 1 |
| Chiang, YK | 1 |
| Webber, LS | 1 |
| Voors, AW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Bogalusa Heart Study[NCT00005129] | 11,737 participants (Actual) | Observational | 1972-06-30 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for propranolol and Weight Gain
| Article | Year |
|---|---|
A Case Report with a Mini-Review of the Literature on the Overeating and Weight Gain Due to Propranolol.
Topics: Humans; Hyperphagia; Propranolol; Weight Gain | 2021 |
6 trials available for propranolol and Weight Gain
| Article | Year |
|---|---|
Serum glucose and lipid changes during the course of clozapine treatment: the effect of concurrent beta-adrenergic antagonist treatment.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Antipsychotic Agents; Atenolol; Blood Gluc | 2003 |
Clinical manifestations of hyperthyroidism after treatment with selective beta 1 adrenoceptor blocking agents.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Atenolol; Fe | 2003 |
Weight variations in the prophylactic therapy of primary headaches: 6-month follow-up.
Topics: Adrenergic beta-Antagonists; Adult; Amines; Amitriptyline; Analgesics, Non-Narcotic; Anticonvulsants | 2005 |
Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Basal Ganglia Diseases; Belgium; Child; Cohort Studies; | 1996 |
Long term propranolol treatment and changes in body weight after myocardial infarction.
Topics: Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Propranolol; Randomiz | 1990 |
Combined low-dose medication and primary intervention over a 30-month period for sustained high blood pressure in childhood.
Topics: Adolescent; Black People; Child; Chlorthalidone; Drug Therapy, Combination; Female; Follow-Up Studie | 1990 |
8 other studies available for propranolol and Weight Gain
| Article | Year |
|---|---|
Voluntary Corn Oil Ingestion Increases Energy Expenditure and Interscapular UCP1 Expression Through the Sympathetic Nerve in C57BL/6 Mice.
Topics: Adipose Tissue, Brown; Animals; Body Temperature Regulation; Corn Oil; Energy Intake; Energy Metabol | 2018 |
EFFECTIVENESS OF FIXED DOSES OF PROPRANOLOL IN THE TREATMENT OF HEMANGIOMAS REGARDLESS OF CHILD'S WEIGHT GAIN: A CASE REPORT.
Topics: Adrenergic beta-Antagonists; Child; Dose-Response Relationship, Drug; Female; Hemangioma; Humans; Pr | 2019 |
Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.
Topics: Adipose Tissue; Animals; Atorvastatin; Blood Glucose; Body Weight; Brain; Dietary Fats; Female; Glut | 2009 |
Ethanolic extracts of Brassica campestris spp. rapa roots prevent high-fat diet-induced obesity via beta(3)-adrenergic regulation of white adipocyte lipolytic activity.
Topics: Adipocytes, White; Adrenergic Agents; Animals; Anti-Obesity Agents; Brassica; Cyclic AMP-Dependent P | 2010 |
Effects of propranolol and atenolol on immobilization stress-induced hypertension and down-regulation of central beta-adrenoceptors in rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Cerebral Cortex; Dihydroalprenolol; | 1995 |
Weight gain induced by long-term propranolol treatment.
Topics: Adult; Female; Humans; Migraine Disorders; Propranolol; Weight Gain | 1993 |
Metabolic consequences of hyperinsulinaemia imposed on normal rats on glucose handling by white adipose tissue, muscles and liver.
Topics: Adipose Tissue; Adrenalectomy; Animals; Blood Glucose; Deoxy Sugars; Deoxyglucose; Energy Intake; Fe | 1990 |
Adrenergic modulation of cardiac development in the rat: effects of prenatal exposure to propranolol via continuous maternal infusion.
Topics: Analysis of Variance; Animals; DNA; Female; Heart; Heart Rate; Infusion Pumps; Litter Size; Myocardi | 1990 |